Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy
Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy have?
Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy has 198 citations in the OpenAlex counts ScholarIQ stores.
When was Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy published?
Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy has 2009 year in the ScholarIQ index.
What is the open-access status of Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy?
Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy has closed oa status in the ScholarIQ index.
What is the DOI of Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy?
The DOI for Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy is on the source record.
What is the PMID of Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy?
The PMID for Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy is on the source record.
What is the OpenAlex record for Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy?
The OpenAlex for Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy is on the source record.